MedPath

秦皇岛紫竹药业有限公司

Ownership
-
Established
2006-01-25
Employees
-
Market Cap
-
Website
http://www.zizhu-pharm.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

NMPA:21

Drug Approvals

Ethinylestradiol

Product Name
炔雌醇
Approval Number
国药准字H20073627
Approval Date
Dec 13, 2021
NMPA

Anisodine Hydrobromide

Product Name
氢溴酸樟柳碱
Approval Number
国药准字H20073633
Approval Date
Dec 13, 2021
NMPA

Estradiol

Product Name
雌二醇
Approval Number
国药准字H20163254
Approval Date
Apr 28, 2021
NMPA

Diethylamine Diclofenate

Product Name
双氯芬酸二乙胺
Approval Number
国药准字H20000467
Approval Date
Aug 16, 2020
NMPA

Ethisterone

Product Name
炔孕酮
Approval Number
国药准字H11021733
Approval Date
Aug 16, 2020
NMPA

Progesterone

Product Name
黄体酮
Approval Number
国药准字H11021732
Approval Date
Aug 16, 2020
NMPA

Testosterone Propionate

Product Name
丙酸睾酮
Approval Number
国药准字H11021750
Approval Date
Aug 16, 2020
NMPA

Barium Sulfate（TypeⅠ)

Product Name
硫酸钡(Ⅰ型)
Approval Number
国药准字H11020040
Approval Date
Aug 13, 2020
NMPA

Quinestrol

Product Name
炔雌醚
Approval Number
国药准字H20103563
Approval Date
Aug 13, 2020
NMPA

Testosterone

Product Name
睾酮
Approval Number
国药准字H20100197
Approval Date
Aug 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.